A Rare Quarterly Appearance by bluebird bio Inc.'s Management
bluebird bio (NASDAQ: BLUE) released third-quarter earnings complete with a conference call, which the biotech doesn't usually hold for quarterly results, but this quarter was different with earnings coinciding with the release of abstracts for the American Society of Hematology (ASH) meeting next month.
Metric
Q3 2017
Source: Fool.com
Bluebird Bio Inc. Stock
€0.85
-5.090%
Our community is currently low on Bluebird Bio Inc. with 4 Buy predictions and 6 Sell predictions.
On the other hand, the target price of 6 € is above the current price of 0.85 € for Bluebird Bio Inc., so the potential is actually 604.89%.
